Sio-Capital-Management
AI_NATIVE detailed information: This accession holds the following tickers:[ null, "AKRO", "ENTA", "AORT", "ANIP", "ANNX", "ATXS", "SVRA", "TVTX", "TERN", "TYRA", "ALGS", "ALEC", "AVTX", "APRE", "AVR", null, "NBIX", "MODD", "NXTC", "OVID", "PRQR", "PMVP", "SEPN", "TELA", "TARA", "IDYA", "ICLR", "HUMAW", "MRK", null, "PRAX", "AQST", "SLNO", "ETNB", "BOLD", "GMED", "HAE", "MMS", "CNTX", "ERAS", "IRWD", "VTYX", "VXRT", "VIR", "AVNS", "FHTX", "LH", "EMBC", "TFX", "ZBH", "BMRN", "DNTH", "IRON" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 54
- Total Value
- 335797884
- Accession Number
- 0001214659-25-007756
- Form Type
- 13F-HR
- Manager Name
- Sio-Capital-Management
Data Enrichment
94% identified51 identified3 unidentified
Holdings
54 positions • $335.8M total value
Manager:
Search and click to pin securities to the top
Page 3 of 3
Shares:177.0K
Value:$977.1K
% of Portfolio:0.3% ($977.1K/$335.8M)
Shares:1.3M
Value:$813.0K
% of Portfolio:0.2% ($813.0K/$335.8M)
Shares:71.5K
Value:$572.4K
% of Portfolio:0.2% ($572.4K/$335.8M)
Shares:276.6K
Value:$564.3K
% of Portfolio:0.2% ($564.3K/$335.8M)
Shares:121.7K
Value:$444.1K
% of Portfolio:0.1% ($444.1K/$335.8M)
B6S7WD106
Shares:50.8K
Value:$354.9K
% of Portfolio:0.1% ($354.9K/$335.8M)
Shares:10.0K
Value:$27.6K
% of Portfolio:0.0% ($27.6K/$335.8M)
77313F114
Shares:400.0K
Value:$17.1K
% of Portfolio:0.0% ($17.1K/$335.8M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
|---|---|---|---|---|---|---|
| 177.0K | All Managers (Combined) | $977.1K | 0.3% ($977.1K/$335.8M) | |||
| 1.3M | QoQ 0.00% (-0)YoY NEW(+1.3M) | All Managers (Combined) | $813.0K | 0.2% ($813.0K/$335.8M) | YoY NEW(+$813.0K) | |
TELA Bio, Inc.(TELAcusip872381108) | 630.0K | QoQ 0.00% (-0)YoY NEW(+630.0K) | All Managers (Combined) | $768.6K | 0.2% ($768.6K/$335.8M) | YoY NEW(+$768.6K) |
| 2.2M | YoY NEW(+2.2M) | All Managers (Combined) | $696.2K | 0.2% ($696.2K/$335.8M) | YoY NEW(+$696.2K) | |
| 71.5K | All Managers (Combined) | $572.4K | 0.2% ($572.4K/$335.8M) | |||
| 276.6K | All Managers (Combined) | $564.3K | 0.2% ($564.3K/$335.8M) | |||
| 121.7K | All Managers (Combined) | $444.1K | 0.1% ($444.1K/$335.8M) | |||
(cusipB6S7WD106)✕ | 50.8K | All Managers (Combined) | $354.9K | 0.1% ($354.9K/$335.8M) | ||
| 252.0K | QoQ 0.00% (-0) | All Managers (Combined) | $274.7K | 0.1% ($274.7K/$335.8M) | ||
| 162.1K | QoQ 0.00% (-0) | All Managers (Combined) | $244.7K | 0.1% ($244.7K/$335.8M) | ||
NextCure, Inc.(NXTCcusip65343E108) | 130.0K | All Managers (Combined) | $62.4K | 0.0% ($62.4K/$335.8M) | ||
| 10.0K | QoQ 0.00% (-0)YoY NEW(+10.0K) | All Managers (Combined) | $27.6K | 0.0% ($27.6K/$335.8M) | YoY NEW(+$27.6K) | |
Humacyte, Inc.(HUMAWcusip44486Q111) | 50.0K | All Managers (Combined) | $18.1K | 0.0% ($18.1K/$335.8M) | ||
(cusip77313F114)✕ | 400.0K | All Managers (Combined) | $17.1K | 0.0% ($17.1K/$335.8M) |